We are live on ! Find out more
GNPX icon

Genprex

6 hedge funds and large institutions have $1.6M invested in Genprex in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

20% more funds holding

Funds holding: 56 (+1)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% less ownership

Funds ownership: 0%0% (-0%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

37% less capital invested

Capital invested by funds: $2.52M → $1.6M (-$923K)

Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.13%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
2
Increased
1
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

GNPX Hedge Fund Activity: Q3 2019 in Review

6 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q3 2019, worth a combined $1.6M — down 37% from $2.52M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new GNPX positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Goldman Sachs, opening a new position worth an estimated $42.2K. The largest seller was Sabby Management, cutting an estimated $84.5K.

  • 6 institutional investors held Genprex (GNPX) as of Q3 2019, up from 5 in Q2 2019.
  • Funds reported $1.6M of Genprex stock for Q3 2019, down 37% quarter-over-quarter.
  • 2 funds opened new Genprex positions in Q3 2019 and 1 closed out, a net change of +1 holder.
  • The largest Genprex buyer in Q3 2019 was Goldman Sachs, an estimated $42.2K added.
  • The largest Genprex seller in Q3 2019 was Sabby Management, an estimated $84.5K sold.

Based on aggregated 13F filings for Q3 2019.